Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sagimet Biosciences's purchase of property, plant, equipment for the
three
months ended in Mar. 2026 was €0.00 Mil. It means Sagimet Biosciences spent €0.00 Mil on purchasing property, plant, equipment.
Sagimet Biosciences's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00Mil.
Compared with last quarter (€0.00 Mil in Dec. 2025 ), Sagimet Biosciences spent the same money on purchasing property, plant, equipment in Mar. 2026 (€0.00 Mil).
Sagimet Biosciences Purchase Of Property, Plant, Equipment Related Terms
Sagimet Biosciences Purchase Of Property, Plant, Equipment Historical Data
* Premium members only.
The historical data trend for Sagimet Biosciences's Purchase Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sagimet Biosciences Purchase Of Property, Plant, Equipment Chart
Sagimet Biosciences Purchase Of Property, Plant, Equipment Calculation
The amount used to purchase PPE.
Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Purchase Of Property, Plant, Equipment of €0.00 Mil mean?
Sagimet Biosciences (STU:0O2) has a Purchase Of Property, Plant, Equipment of €0.00 Mil as of Mar. 2026. Purchase of PP&E is the total purchase of property, plant and equipment. View historical data for Sagimet Biosciences and its competitors.
Is Sagimet Biosciences' Purchase Of Property, Plant, Equipment too high?
Sagimet Biosciences' current Purchase Of Property, Plant, Equipment is €0.00 Mil. Overall, Sagimet Biosciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sagimet Biosciences' Purchase Of Property, Plant, Equipment compare to EDIT and AUTL?
Sagimet Biosciences' Purchase Of Property, Plant, Equipment of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Purchase Of Property, Plant, Equipment for a Biotechnology company?
A good Purchase Of Property, Plant, Equipment depends on the Biotechnology industry context. However, Purchase Of Property, Plant, Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Purchase Of Property, Plant, Equipment mean?
A high Purchase Of Property, Plant, Equipment can signal that a stock is expensive relative to its fundamentals. Purchase of PP&E is the total purchase of property, plant and equipment. View historical data for Sagimet Biosciences and its competitors. Sagimet Biosciences's current Purchase Of Property, Plant, Equipment is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sagimet Biosciences stock overvalued right now?
Sagimet Biosciences (STU:0O2) has a current Purchase Of Property, Plant, Equipment of €0.00 Mil. The current Purchase Of Property, Plant, Equipment is €0.00 Mil. Sagimet Biosciences' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Purchase Of Property, Plant, Equipment calculated?
Purchase Of Property, Plant, Equipment is calculated from a company's financial statements. For Sagimet Biosciences (STU:0O2), the current Purchase Of Property, Plant, Equipment is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.
18GF Score
Get the complete analysis for STU:0O2
Purchase Of Property, Plant, Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0O2 has been successfully added to your 
